Advertisement

Topics

Mirna Therapeutics, Inc. Company Profile

06:34 EST 11th December 2018 | BioPortfolio

Mirna Therapeutics is a biotechnology company focused on the development and commercialization of microRNA (miRNA) therapeutics. The Company has a substantial body of pending intellectual property around miRNAs developed by its own scientists as well as in-licensed from other institutions. Mirna’s IP portfolio contains >300 miRNAs with applications in oncology and other diseases. Oncology-directed miRNAs include those that are key tumor suppressors in cancer, such as miR-34 and let-7 that have proven to block tumor growth in a number of different pre-clinical animal studies. The Company, founded in 2007, is located in Austin, Texas. For more information, visit www.mirnarx.com.


News Articles [720 Associated News Articles listed on BioPortfolio]

xMD-miRNA-seq to generate near in vivo miRNA expression estimates in colon epithelial cells

HTG Introduces the HTG EdgeSeq Mouse miRNA Whole Transcriptome Assay

HTG Molecular Diagnostics (Nasdaq:HTGM) a provider of instruments, reagents, and services for molecular profiling applications, today announced the pre-launch introduction of the new HTG EdgeSeq Mous...

Diagnostics and Therapeutics for Adrenocortical Carcinomas

The National Cancer Institute's Endocrine Oncology Branch seeks parties to co-develop diagnostic that target altered human miRNA expression such as miRNA-483 and miRNA 100 to accurately predict if a p...

BioXcel Therapeutics Appoints Vincent O’Neill Chief Medical Officer

Vincent O’Neill has been appointed senior vice president and chief medical officer of BioXcel Therapeutics (NASDAQ: BTAI). O’Neill had been serving as chief medical officer of the Branford, CT, co...

Drug delivery using miRNA-enriched extracellular vesicles

Researchers have developed a method of producing extracellular vesicles on a large scale to deliver drugs offering a standardised method of manufacture... The post Drug delivery using miRNA-enriched e...

Targeting sepsis, the leading cause of ICU deaths, with a nanocarrier-delivered microRNA

(Medical University of South Carolina) One obstacle to therapeutic use of microRNAs (miRNA), which are in clinical trial for a number of diseases, are ribonucleases, whose job it is to destroy them. M...

#Crohns Subtype Accurately Predicted through miRNA Molecule: http://ow.ly/djfs30mfNBp pic.twitter.com/fGCFJKVYLP

#Crohns Subtype Accurately Predicted through miRNA Molecule: http://ow.ly/djfs30mfNBp  pic.twitter.com/fGCFJKVYLP

#Crohns Subtype Accurately Predicted through miRNA Molecule: http://ow.ly/djfs30mfNBp pic.twitter.com/DM0bhAXwZT

#Crohns Subtype Accurately Predicted through miRNA Molecule: http://ow.ly/djfs30mfNBp  pic.twitter.com/DM0bhAXwZT

PubMed Articles [955 Associated PubMed Articles listed on BioPortfolio]

MicroRNA-based therapeutics in central nervous system injuries.

Central nervous system (CNS) injuries, such as stroke, traumatic brain injury (TBI) and spinal cord injury (SCI), are important causes of death and long-term disability worldwide. MicroRNA (miRNA), sm...

Targeting miRNA for Therapeutics Using a Micronome Based Method for Identification of miRNA-mRNA Pairs and Validation of Key Regulator miRNA.

MicroRNAs are 18-22 bp long non-coding sequences and play a critical role in diverse biological processes, through modulation of gene expression at the post-transcriptional level by binding at the 3'...

Five Common Functional Polymorphisms in microRNAs and Susceptibility to Breast Cancer: An Updated Meta-Analysis.

microRNAs (miRNA) play a key role in the pathogenesis of breast cancer (BC) as regulators of tumor-associated genes, and understanding their polymorphisms is critical to the control of breast carcinog...

Serum exosomal microRNAs as potent circulating biomarkers for melanoma.

Exosomes are small homogenous membrane vesicles that derive from the exocytosis process of cells and can contain DNA, microRNAs (miRNAs), and/or proteins. Characterization of the content profile of ex...

A Simplified System to Express Circularized Inhibitors of miRNA for Stable and Potent Suppression of miRNA Functions.

MicroRNAs (miRNAs) are an evolutionarily conserved class of small regulatory noncoding RNAs, binding to complementary target mRNAs and resulting in mRNA translational inhibition or degradation, and th...

Clinical Trials [228 Associated Clinical Trials listed on BioPortfolio]

microRNA Expression in Renal Cell Carcinoma

In this study, renal cell carcinoma (RCC) related miRNA and the target genes of related miRNA will be examined in order to investigate the role of miRNA in the formation of RCC and look fo...

Non-coding RNA in the Exosome of the Epithelia Ovarian Cancer

This study aims to analyze the expression of micro-RNA (miRNA) and long non-coding RNA (lncRNA) by next-generation sequencing in patients with high grade serous ovarian cancer (HGSOC) and ...

Plasma microRNA Profiling as First Line Screening Test for Lung Cancer Detection: a Prospective Study

In the present project we propose a large prospective study in heavy smokers volunteers based on plasma miRNA profiling to assess its efficacy as a first line screening test for lung cance...

miRNA Profile in Aneurysmal Subarachnoid Haemorrhage

The investigators aim to investigate and understand the circulating miRNA profiles after acute aneurysmal subarachnoid haemorrhage and underlying pathological significance.

Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas

MicroRNAs (miRNA) are molecular biomarkers that post-transcriptionally control target genes. Deregulated miRNA expression has been observed in diverse cancers. In high grade gliomas, know...

Companies [1297 Associated Companies listed on BioPortfolio]

Mirna Therapeutics Inc.

Mirna Therapeutics is a biotechnology company focused on the development and commercialization of microRNA (miRNA) therapeutics. The Company has a substantial body of pending i...

Mirna Therapeutics, Inc. and Horizon Discovery Ltd.

Mirna Therapeutics, Inc. (Mirna) is a biotechnology company focused on the development and commercialization of miRNA therapeutics. The Company has a foundational intellectual pro...

Mirna Therapeutics

Mirna Therapeutics, Inc. (Mirna) is a biotechnology company founded in late 2007 as a spin-off from Asuragen Inc. and is located in Austin, Texas. Mirna is focused on the developm...

Mirna Therapeutics, Inc.

Mirna Therapeutics is a biotechnology company focused on the development and commercialization of microRNA (miRNA) therapeutics. The Company has a substantial body of pending inte...

Synlogic, Inc. and Mirna Therapeutics, Inc.

More Information about "Mirna Therapeutics, Inc." on BioPortfolio

We have published hundreds of Mirna Therapeutics, Inc. news stories on BioPortfolio along with dozens of Mirna Therapeutics, Inc. Clinical Trials and PubMed Articles about Mirna Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mirna Therapeutics, Inc. Companies in our database. You can also find out about relevant Mirna Therapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record